Fines & Sanctions
CT Joins $1.2 Billion Settlement With Johnson & Johnson, Janssen
|
Connecticut will receive more than $10 million in one of the largest pharmaceutical fraud settlements in history, as Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, Inc., resolve allegations of unlawfully marketing two antipsychotic drugs, including Risperdal, heavily used among nursing-home patients.




